Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaginal Atrophy in Breast Cancer Patients”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)Study completedNCT00607295
What this trial is testing

Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients

Who this might be right for
Breast CancerVaginal Atrophy
Seoul National University Hospital 98
Post-approval studies (Phase 4)Study completedNCT04705883
What this trial is testing

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors

Who this might be right for
Vulvar AtrophyBreast CancerGenitourinary Syndrome of Menopause
Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)Study completedNCT06654570
What this trial is testing

Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial

Who this might be right for
Breast Cancer
Helsinki University Central Hospital 20
Not applicableLooking for participantsNCT06828640
What this trial is testing

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

Who this might be right for
Vulvo Vaginal AtrophyGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy in Breast Cancer Patients+4 more
Centre Hospitalier Universitaire Saint Pierre 160
Testing effectiveness (Phase 2)WithdrawnNCT03666819
What this trial is testing

Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+26 more
Mayo Clinic
Large-scale testing (Phase 3)WithdrawnNCT03740945
What this trial is testing

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Who this might be right for
Vaginal Atrophy in Breast Cancer Patients
EndoCeutics Inc.
Not applicableUnknownNCT03628092
What this trial is testing

Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients

Who this might be right for
Vulvovaginal AtrophyGenitourinary Symptoms and Ill-Defined Conditions
Royal North Shore Hospital 70
Not applicableLooking for participantsNCT06900374
What this trial is testing

Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

Who this might be right for
Vaginal DrynessBreast CancerVulvovaginal Atrophy
Centre Oscar Lambret 75
Not applicableNot Yet RecruitingNCT05585476
What this trial is testing

A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.

Who this might be right for
Female Urogenital DiseasesBreast Cancer Female
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 180
Early research (Phase 1)Study completedNCT01370551
What this trial is testing

Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients

Who this might be right for
Atrophic Vaginitis
Medinova AG 16